| 2001 |
The GoLoco motif of RGS14 interacts exclusively with Gαi1, Gαi2, and Gαi3 in their GDP-bound forms and exhibits guanine nucleotide dissociation inhibitor (GDI) activity, inhibiting the rate of GDP-to-GTP exchange on Gαi1 and stabilizing the GDP-bound state. This is distinct from the N-terminal RGS box, which confers GTPase-accelerating protein (GAP) activity on Gαi/o subunits, establishing that RGS14 has two independent Gα interaction sites with different biochemical activities. |
GTPγS binding assays, intrinsic tryptophan fluorescence assays, in vitro binding experiments with purified proteins |
The Journal of biological chemistry |
High |
11387333
|
| 2000 |
RGS14 binds activated Rap1 and Rap2 (but not Ras) through a domain distinct from the RGS domain that shares sequence identity with the Ras/Rap binding domain of B-Raf and Raf-1 kinases. RGS14 preferentially stimulates GTPase activity of Gαo over Gαi1 in brain membranes and in reconstitution assays. |
Yeast two-hybrid, in vitro binding with Rap2 mutants, GTPase assays with brain membranes, deletion analysis |
The Biochemical journal |
High |
10926822
|
| 2000 |
RGS14 acts as a GAP for Gαi subfamily members and attenuates IL-8 receptor-mediated MAPK activation. RGS14 does not exhibit GAP activity toward Gαs or Gαq. Although not a GAP for G12/13α, RGS14 impairs G13α-mediated c-fos SRE activation. An RGS14 mutant (EN92/93AA) defective in Gαi signaling inhibition still blocks SRE activation. RGS14 localizes predominantly to the cytosol but is recruited to membranes by constitutively active G13αQ226L. |
GTPase assays, cell-based signaling reporter assays, subcellular fractionation, dominant-negative mutant analysis |
Molecular pharmacology |
Medium |
10953050
|
| 2001 |
Full-length RGS14 in brain exists in two immunoreactive forms (~60 kDa and ~55 kDa) in cytosol and two membrane subpopulations. Recombinant RGS14 is a non-selective GAP for Gαi1 and Gαo, with full-length RGS14 approximately 10-fold more potent than the isolated RGS domain alone. GDI activity toward Gαi (but not Gαo) is restricted to the C-terminus containing the GoLoco domain, and the isolated RBD domain does not act as a GAP for Rap1. |
Immunoblotting with affinity-purified antisera, reconstitution GTPase assays, pulldown from brain membranes |
Journal of neurochemistry |
High |
11739605
|
| 2003 |
PKA phosphorylates RGS14 at two specific sites in response to cAMP elevation; one site, threonine 494 (Thr494), is immediately adjacent to the GoLoco motif. Mimicking phosphorylation at Thr494 enhanced GDI activity of RGS14 toward Gαi nearly 3-fold without affecting GAP activity toward Gαi or Gαo. |
Radiolabeled phosphate incorporation, PKA inhibitor experiments, phosphomimetic mutant biochemical assays, cAMP stimulation in cells |
Biochemistry |
High |
12534294
|
| 2004 |
The RGS14 GoLoco domain discriminates among Gαi isoforms: it inhibits guanine nucleotide exchange on Gαi1 and Gαi3, but not Gαi2. Gαi2 could be rendered sensitive to RGS14 GDI activity by replacing residues within the αA/αB and αB/αC loops of the α-helical domain, identifying these loops as key selectivity determinants. |
In vitro GTPγS binding assays, Gαi2 chimeric mutant analysis |
The Journal of biological chemistry |
High |
15337739
|
| 2004 |
RGS14 is expressed in mouse embryos immediately prior to the first mitosis, colocalizes with the anastral mitotic apparatus of the mouse zygote, and is essential for completion of the first mitotic division. Loss of Rgs14 in the zygote causes cytofragmentation and failure to progress to the 2-cell stage. During interphase in proliferating cells RGS14 segregates to the nucleus, and during mitosis it localizes to the mitotic spindle and centrioles. Altering RGS14 levels in proliferating cells causes growth arrest. |
Loss-of-function in mouse embryos, colocalization imaging, overexpression/knockdown in proliferating cells |
Developmental cell |
High |
15525537
|
| 2004 |
The RGS and GoLoco domains of RGS14 are independently able to inhibit signaling downstream of Gi via the βγ pathway. Targeting the isolated GoLoco domain to membranes (by myristoylation/palmitoylation or Rap binding) enhances its inhibitory activity. In the context of full-length RGS14, the RGS and GoLoco domains cooperate to confer maximal inhibition of Gi signaling. |
Cell-based signaling assays in HEK-m2 cells with domain mutants and truncation constructs, myristoylation targeting constructs |
The Biochemical journal |
Medium |
15112653
|
| 2004 |
RGS14 localizes to centrosomes via its first Ras-binding domain, and shuttles between cytoplasm and nucleus via CRM-1-dependent nuclear export. Mutation of the nuclear export signal or leptomycin B treatment causes nuclear accumulation and association with PML nuclear bodies. A mutant defective in nuclear export also fails to target to centrosomes, indicating that nucleocytoplasmic shuttling is required for centrosomal localization. |
Immunofluorescence, leptomycin B treatment, NES mutant analysis, domain deletion constructs |
The Journal of biological chemistry |
Medium |
15520006
|
| 2005 |
RGS14 is a microtubule-associated protein that binds directly to polymerized (but not depolymerized) microtubules with Kd ~1.3 μM. RGS14 copurifies with tubulin through multiple polymerization/depolymerization cycles from brain. Both RGS14 and Gαi1-GTP promote tubulin polymerization in the presence of microtubule-associated proteins, but preincubation of RGS14 with Gαi1-GDP abolishes this activity. Depletion of RGS14 from cell extracts blocks mitotic aster formation in vitro. |
Microtubule co-sedimentation, direct binding to pure tubulin with Kd measurement, brain extract purification, in vitro aster formation assay, RGS14 depletion |
Cell cycle (Georgetown, Tex.) |
High |
15917656
|
| 2005 |
The RBD/GoLoco region of RGS14 (lacking the RGS domain) binds Gαo-GDP, Gαi-GDP, and Gβγ in brain pull-down assays. In reconstituted receptor-G protein systems, this region potentiates RGS4 GAP activity by increasing the apparent affinity of RGS4 for Gαi and Gαo, an activity requiring membranes and/or receptors. |
Brain pull-down assays, reconstituted M2 receptor/G-protein GTPase assays, steady-state GTPase measurements |
Biochemistry |
Medium |
15807543
|
| 2006 |
RGS14 subcellular localization in HeLa cells is controlled by distinct domains: localization to the nucleus requires the RGS and RBD domains; translocation out of the nucleus depends on the GoLoco/GPR domain; localization to centrosomes depends on the RBD domain. RGS14 binds directly to both inactive (GDP) and active (GTP) forms of Gαi1 and Gαi3, but not Gαi2, and binding to inactive Gαi1/3 at the plasma membrane prevents nuclear or centrosomal association. |
Confocal imaging of GFP-tagged constructs with domain mutations, co-immunoprecipitation with Gαi isoforms from cells |
Cellular signalling |
Medium |
16870394
|
| 2006 |
RGS14 GAP activity and GDI activity toward heterotrimeric G proteins are unaffected by Rap1/Rap2 binding. A heterotrimer composed of N-myristoylated Gαi1 and prenylated Gβγ is resistant to the GDI activity of the RGS14 GoLoco domain, suggesting RGS14 alone cannot dissociate intact heterotrimers. |
In vitro GTPase assays, GDI assays with assembled heterotrimer, Rap-binding competition experiments |
The Biochemical journal |
Medium |
16246175
|
| 2009 |
In cellular contexts, RGS14 selectively binds activated H-Ras-GTP (not Rap isoforms), assembles a multiprotein complex with components of the ERK MAPK pathway (Raf, MEK, ERK) in an H-Ras-GTP-dependent manner, and promotes sustained ERK activation. siRNA knockdown of RGS14 inhibited NGF- and bFGF-mediated neuronal differentiation of PC12 cells, a process dependent on Ras-ERK signaling. |
Co-immunoprecipitation, siRNA knockdown, PC12 neurite outgrowth assays, ERK phosphorylation assays |
PloS one |
Medium |
19319189
|
| 2010 |
RGS14 is highly enriched in CA2 pyramidal neurons and suppresses long-term potentiation (LTP) at Schaffer collateral synapses. Deletion of RGS14 (exons 2–7 knockout) enables robust LTP at CA2 synapses without affecting CA1 plasticity. MEK inhibition blocks LTP in RGS14-deficient CA2 neurons, implicating ERK/MAP kinase signaling. RGS14 KO mice show enhanced spatial learning and object recognition memory without deficits in non-hippocampal tasks. |
Genetic knockout mice, electrophysiology (LTP recordings), MEK inhibitor pharmacology, behavioral testing |
Proceedings of the National Academy of Sciences of the United States of America |
High |
20837545
|
| 2010 |
Activated H-Ras binds RGS14 at the R1 Ras-binding domain (RBD) to form a stable complex at cell membranes. RGS14 co-localizes with and forms a complex with Raf kinases in cells, and the regulatory region of Raf-1 binds the RBD region of RGS14. H-Ras and Raf facilitate one another's binding to RGS14. RGS14 selectively inhibits PDGF- but not EGF- or serum-stimulated ERK phosphorylation, dependent on H-Ras binding. Gαi1 binding to RGS14 is mutually exclusive with Raf binding, and Gαi1 recruits RGS14 to the plasma membrane to reverse inhibition of ERK signaling. |
Co-immunoprecipitation, subcellular localization imaging, ERK phosphorylation assays, domain mutant analysis |
Cellular signalling |
Medium |
19878719
|
| 2011 |
RGS14 forms a Gαi/o-dependent complex with the α2A-adrenergic receptor (α2A-AR) in live cells, as measured by BRET. Receptor agonist (UK14304) stimulation disrupts the RGS14·α2A-AR complex while preserving the RGS14·Gαi1 complex. Ric-8A (a non-receptor GEF) facilitates dissociation of both the RGS14·Gαi1 complex and the Gαi1-dependent RGS14·α2A-AR complex after receptor activation. |
Bioluminescence resonance energy transfer (BRET) in live cells, pharmacological receptor stimulation |
The Journal of biological chemistry |
Medium |
21880739
|
| 2012 |
RGS14 preferentially binds activated H-Ras-GTP in live cells, and inactive Gαi1-GDP markedly enhances RGS14 affinity for H-Ras-GTP (but active Gαi1-GTP does not). Active H-Ras-GTP interacts with a native RGS14·Gαi1 complex in brain lysates. Co-expression of RGS14 and Gαi1 in PC12 cells greatly enhances H-Ras-stimulatory effects on neurite outgrowth. Stimulation of α2A-AR induces a conformational change in the Gαi1·RGS14·H-Ras ternary complex. |
BRET in live cells, co-immunoprecipitation from brain lysates, PC12 neurite outgrowth assays |
The Journal of biological chemistry |
High |
23250758
|
| 2013 |
The RBD region of RGS14 mediates an intramolecular interaction that enhances GAP activity of the RGS domain while simultaneously inhibiting GDI activity of the GPSM/GoLoco domain. The RBD region also binds members of the B/R4 subfamily of RGS proteins and enhances their effects on GPCR-activated Gi/o proteins. |
In vitro GTPase/GDI assays with isolated domains and full-length protein, protein-protein binding assays |
Journal of cellular biochemistry |
Medium |
23255434
|
| 2015 |
RGS14 forms a stable complex with inactive Gαi1-GDP at the plasma membrane via its GPR motif and is also recruited to the plasma membrane by activated Gαo-AlF4(-) via its RGS domain. RGS14 undergoes allosteric conformational changes upon Gαi1-GDP binding to the GPR motif, as revealed by hydrogen/deuterium exchange mass spectrometry. RGS14 can form a ternary complex with Gαo-AlF4(-) and a Gαi1-GDP mutant (G42R) simultaneously, and a preformed RGS14·Gαi1-GDP complex retains full capacity to stimulate GTPase activity of Gαo-GTP. |
Size exclusion chromatography, hydrogen/deuterium exchange mass spectrometry (HDX-MS), BRET, biochemical reconstitution, cellular localization assays |
The Journal of biological chemistry |
High |
25666614
|
| 2016 |
RGS14 acts as a dedicated GAP for Gαo/i signaling and does not prolong Gβγ signaling following receptor activation. Co-expression of RGS14 inhibits free Gβγ release after agonist stimulation and increases the deactivation rate of Gα, consistent with GAP activity. Overexpression of inactive Gαi1 to recruit RGS14 to the plasma membrane did not alter RGS14's GAP activity toward a second Gαo protein, indicating the GPR motif functions independently of the RGS domain for GAP activity. |
BRET in live cells, GPCR agonist/antagonist kinetics analysis |
Pharmacology research & perspectives |
Medium |
27713821
|
| 2017 |
Endogenous RGS14 in neuroblastoma (B35) cells localizes to juxtanuclear membranes encircling the nucleus, at nuclear pore complexes on both sides of the nuclear envelope and within intranuclear membrane channels, and within chromatin-rich and chromatin-poor nuclear regions in a cell-cycle-dependent manner. Endogenous RGS14 was absent from the plasma membrane in resting cells but could be trafficked to the plasma membrane from juxtanuclear membranes (derived from ER/Golgi) following AlF4¯ activation of its G protein binding partners. |
Confocal imaging, 3D-structured illumination microscopy, AlF4¯ pharmacological activation, subcellular fractionation |
PloS one |
Medium |
28934222
|
| 2018 |
RGS14 directly interacts with Ca2+/calmodulin (CaM) and is phosphorylated by CaMKII in vitro. RGS14 associates with CaMKII and CaM in hippocampal CA2 neurons in vivo. These interactions were identified via immunoprecipitation-mass spectrometry proteomics of endogenous RGS14 from mouse brain, validated by direct biochemical binding assays. |
Immunoprecipitation-mass spectrometry from mouse brain, direct binding assays, in vitro CaMKII phosphorylation assay, confocal colocalization |
Journal of proteome research |
Medium |
29518331
|
| 2018 |
RGS14 suppresses plasticity in hippocampal area CA2 by restricting calcium (Ca2+) elevations in dendritic spines. Genetic KO of RGS14 results in nascent LTP requiring NMDA receptors, CaMK, and PKA. WT CA2 neurons display significantly attenuated spine Ca2+ transients during structural plasticity induction compared with RGS14 KO CA2 or CA1 controls. Acute overexpression of RGS14 is sufficient to block spine structural plasticity, and elevated extracellular Ca2+ restores plasticity to RGS14-expressing neurons. |
Genetic KO mice, two-photon calcium imaging in dendritic spines, pharmacological inhibition (NMDA receptor, CaMK, PKA antagonists), overexpression experiments |
eNeuro |
High |
29911178
|
| 2018 |
14-3-3γ directly binds RGS14 at two distinct sites: one phosphorylation-independent site and one phosphorylation-dependent site at Ser-218, potentiated by active H-Ras signaling. The pSer-218-dependent interaction inhibits active Gαi1-AlF4- binding to the RGS domain but does not affect H-Ras or inactive Gαi1-GDP binding. The phosphorylation-independent 14-3-3 interaction inhibits RGS14 nuclear import/nucleocytoplasmic shuttling without affecting Gαi interactions. |
BRET in live cells, direct binding assays, site-directed mutagenesis at Ser-218 |
The Journal of biological chemistry |
Medium |
30093406
|
| 2020 |
Human genetic variants L505R (LR) and R507Q (RQ) in the nuclear export sequence of RGS14 disrupt RGS14 binding to Gαi1-GDP and to Exportin 1 (XPO1), disturb nucleocytoplasmic equilibrium, and abolish RGS14's capacity to inhibit LTP. Variant LR accumulates irreversibly in the nucleus, preventing membrane localization to dendritic spines. When introduced into mice by CRISPR/Cas9, RGS14-LR is predominantly nuclear in neurons of hippocampus, amygdala, piriform cortex, and striatum. Unlike complete RGS14 KO, LR mice show normal spatial learning, suggesting distinct nuclear vs. dendritic spine functions. |
Site-directed mutagenesis, co-immunoprecipitation, electrophysiology (LTP), CRISPR/Cas9 knock-in mice, confocal imaging, behavioral testing |
The Journal of biological chemistry |
High |
33410399
|
| 2022 |
RGS14 possesses a carboxy-terminal PDZ ligand required for binding to NHERF1 scaffold protein (at PDZ2) and thereby regulates NPT2A-mediated renal phosphate transport. RGS14 blocks PTH- and FGF23-induced dissociation of the NPT2A-NHERF1 complex and thereby suppresses hormone-sensitive (but not basal) phosphate uptake. RGS14 genetic variants bearing mutations in the PDZ ligand disrupt NHERF1 binding and PTH-sensitive phosphate transport. RGS14 does not affect PTH-directed G protein activation or cAMP formation, implying a post-receptor site of action. |
Isotope uptake measurements, BRET assays, siRNA knockdown, pull-down and overlay assays, molecular modeling, direct binding assays in proximal tubule cells |
The Journal of biological chemistry |
High |
35307350
|
| 2007 |
RGS14 associates with mu-opioid receptors (MOR) in periaqueductal gray (PAG) neurons. When RGS14 is silenced, morphine increases serine 375 phosphorylation of MOR (a GRK substrate), leading to receptor internalization and recycling and resensitization to morphine with reduced tolerance. RGS14 prevents GRKs from phosphorylating MOR residues required for β-arrestin-mediated endocytosis. Morphine (but not DAMGO) also triggers CaMKII activation in PAG neurons via a mechanism requiring RGS14. |
siRNA knockdown in vivo, receptor phosphorylation assays, internalization/recycling assays, behavioral antinociception measurement |
Cellular signalling |
Medium |
17825524
|
| 2013 |
RGS14 regulates αMβ2 integrin activation during phagocytosis in macrophages. Exogenous RGS14 expression in COS-7 cells increases binding of C3bi-opsonized targets. Knockdown of RGS14 in J774.A1 macrophages decreases association with C3bi-opsonized particles. This function requires the R333 residue of the RGS14 RBD and the F754 residue of β2, indicating regulation occurs through the Rap/RBD axis. |
Exogenous expression, siRNA knockdown, binding assays with opsonized particles, point mutant analysis |
PloS one |
Medium |
23805333
|
| 2023 |
RGS14 localizes to mitochondria in hippocampal CA2 pyramidal cells and reduces mitochondrial respiration in vitro. Loss of RGS14 dramatically increases 3-nitrotyrosine levels (oxidative stress marker) in CA2 cells, which is exacerbated following kainic acid-induced status epilepticus and correlates with a lack of SOD2 induction. RGS14 KO mice show accelerated onset of limbic motor seizures and increased mortality. RGS14 KO also results in absence of microgliosis in CA1 and CA2 following seizure. |
Mitochondrial localization imaging, in vitro mitochondrial respiration assay, kainic acid seizure model in KO mice, proteomics, immunostaining for oxidative stress markers |
Neurobiology of disease |
Medium |
37075948
|
| 2025 |
Small-molecule inhibitors targeting the solvent-exposed 'canyon' in the RGS14 RGS-box that interacts with the Gα switch I region can non-covalently and selectively inhibit RGS14 GAP activity. Two second-generation analogs (Z55660043 and Z55627844) inhibited RGS14 GAP activity in both fluorescence-based and radioactive GTP hydrolysis assays without measurable cytotoxicity. One analog showed favorable in vivo pharmacokinetics and CNS penetration. |
Structure-guided virtual screening, fluorescence-based GAP assays, radioactive GTP hydrolysis assays, cytotoxicity assays, in vivo pharmacokinetics |
bioRxivpreprint |
Medium |
bio_10.1101_2025.06.11.659181
|
| 2025 |
RGS14 physically interacts with GNAI3 (Gαi3) in spermatogonial stem cells (SSCs), as shown by co-immunoprecipitation. RGS14 knockdown suppresses SSC proliferation, induces apoptosis, inhibits PLPP2 expression, and reduces MAPK signaling activation. Overexpression of PLPP2 rescues phenotypic defects caused by RGS14 depletion, identifying a RGS14–GNAI3–PLPP2 regulatory axis. |
Single-cell RNA sequencing, siRNA knockdown, co-immunoprecipitation, RNA sequencing, PLPP2 rescue overexpression, proliferation/apoptosis assays |
Frontiers in cell and developmental biology |
Medium |
40352663
|
| 2025 |
RGS14 regulates hormone-sensitive renal phosphate transport through a linker region between the RGS and RBD1 domains: Ser266 and Ser269 within this α-helical linker are phosphorylated in response to PTH and FGF23. Ser266Ala/Ser269Ala substitutions abolish RGS14 regulatory effects on hormone-sensitive phosphate transport while an intact PDZ ligand is also required. Truncation constructs lacking the RGS domain are fully functional for phosphate transport regulation. |
RGS14 truncation constructs, phosphorylation assays with PTH and FGF23, phosphate uptake measurements, alanine mutagenesis of Ser266/Ser269 |
The Biochemical journal |
Medium |
39792018
|